“The number of global focused ultrasound device manufacturers has surged from just five a decade ago to more than one hundred today. Industry consolidation is inevitable, and Chongqing HAIFU Technology is undoubtedly a leading manufacturer in this field.”

This high praise was recently delivered by Dr. Neal F. Kassell, Chairman of the Focused Ultrasound Foundation (FUSF), during an interview on the News Items podcast. His remarks vividly underscore the explosive growth of the focused ultrasound industry while further highlighting the rising global leadership of original Chinese innovation.

Focused Ultrasound: Redefining the Future of Non-Invasive Therapy

As modern surgery evolves from open procedures to minimally invasive—and ultimately non-invasive—approaches, focused ultrasound technology has emerged as a transformative force reshaping the rules of traditional surgical treatment.

Developed through original Chinese innovation, the HAIFU® (High-Intensity Focused Ultrasound Tumor Therapeutic System) system,  leverages the mechanical, thermal, and cavitation effects of focused ultrasound to induce irreversible coagulative necrosis in target tissues. This enables truly non-invasive treatment—without incisions, bleeding, radiation exposure, or physical surgical pathways.

The technology allows for precise, conformal, one-time ablation of diseased tissue while preserving surrounding organs, anatomical structures, and physiological function, opening entirely new therapeutic pathways for tumor treatment and beyond.

Recognition Rooted in Firsthand Experience

Dr. Kassell’s recognition is the result of extensive, firsthand engagement rather than coincidence. In October 2023, he personally led a delegation to Chongqing to conduct an in-depth on-site evaluation of HAIFU Technology’s scientific research, device innovation, and clinical achievements in focused ultrasound therapy.

Following this visit, Dr. Kassell formally proposed expanded collaboration in clinical research, Centers of Excellence development, and global education and training.

In early 2025, the Focused Ultrasound Foundation officially designated Chongqing Haifu Hospital as its 13th global Center of Excellence—and the first in China. This milestone marked the first inclusion of a Chinese institution among the Foundation’s elite network, which includes world-renowned organizations from Oxford University, Stanford University, and the University of Maryland, among others.

A Global Authority in Focused Ultrasound Advancement

The Focused Ultrasound Foundation is one of the most influential non-governmental organizations in the field, dedicated to advancing focused ultrasound therapy worldwide. Its work spans clinical translation, technology standards, education, and global advocacy.

In October 2022, the Foundation awarded the world’s first Focused Ultrasound “Clinical Application Award” to Professor Zhibiao Wang of Chongqing Medical University and the HAIFU team, recognizing more than three decades of pioneering contributions in fundamental research, device development, clinical application, and international standard-setting.

Sustained Innovation Driving Global Expansion

Industry data continue to confirm the accelerating momentum of focused ultrasound worldwide. A 20-fold increase in global manufacturers over the past decade reflects surging clinical demand and growing technological maturity.

Within this rapidly evolving landscape, Chongqing HAIFU Technology has maintained its leadership through sustained original innovation. Its product portfolio now spans oncology treatment, common disease management, and rehabilitation and wellness, with market approvals in over 40 countries and regions, including China NMPA and EU CE certification.

As of November 2025, HAIFU ®systems have been exported to 36 countries and regions, including the United Kingdom, Germany, and Saudi Arabia, enabling approximately 350,000 patients worldwide to receive non-invasive, organ-preserving treatment for benign and malignant tumors.

Setting Global Standards, Training Global Experts

Beyond technology development, HAIFU Technology has led or participated in the formulation of more than ten national and industry standards, establishing itself as a global standard-setter and innovation source in focused ultrasound therapy.

By the end of 2024, the company had trained over 3,000 physicians from 135 countries and regions, supported by a global remote service center that delivers continuous technical guidance and professional education, cultivating the next generation of non-invasive therapy specialists worldwide.

A Chinese Innovation Reshaping Global Healthcare

As focused ultrasound continues to break new ground across complex and challenging diseases, and as HAIFU® systems bring non-invasive treatment hope to patients around the world, a medical revolution led by China is reshaping the global competitive landscape of high-end medical equipment.

Guided by the human-centered philosophy of “Treatment —— Minimize Harm to Patients,” HAIFU Technology remains committed to delivering enduring Chinese innovation to advance global healthcare and improve lives worldwide.